Care for Late Stage Parkinsonism

Care for Late Stage Parkinsonism - CLaSP

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

NL-OMON

Registry ID

NL-OMON41035

Enrollment

120

Registered

2014-12-10

Start date

2015-01-14

Completion date

Unknown

Last updated

2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

Management suggestions to the primary clinician involved in the care for the patient, made by the senior physician/researcher at baseline following the medical assessment, taking into account curren

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Diagnosed with Parkinson's disease AND;- Hoehn and Yahr stages IV or V during 'On' phase; OR - Significant levels of disability (Schwab and England stage 50% or less) in *On* and a disease duration of at least 7 years

Exclusion criteria

Exclusion criteria: Hoehn and Yahr stages I-III Symptomatic Parkinsonism Patients with Parkinsonism with a clear history of dementia occuring before the onset of Parkinsonism

Design outcomes

Primary

Measure	Time frame
UPDRS-ADL disability measure	—

Secondary

Measure	Time frame
Quality of life: - Patients* and carers* quality of life - Patients* and carers* satisfaction with care - Meaning in Life Other palliative care aspects - Symptom burden in late stage Parkinsonism - Carer burden - Palliative care status - Nutritional status/BMI - Nursing home placement/institutionalisation - Place of death - Mortality Health care utilization Process evaluation: * Sampling quality: Proportion of eligible patients participating in the study, i.e. reach. * Intervention quality: -To what extent is the CLaSP-intervention implemented, ie. level of implementation? -What are the barriers and facilitators to implementation? * Reach: During patient recruitment, the researcher documents: -Number of potential participants, identified in databases and other sources, receiving a invitation letter for participation. -Number of potential participants agreeing to participate, before screening on eligibility -Number of participant fulfilling inclusion criteria and included in the study -Number of participant not fulfilling inclusion criteria and reasons for exclusion	—

Measure

Time frame

Quality of life: - Patients* and carers* quality of life - Patients* and carers* satisfaction with care - Meaning in Life Other palliative care aspects - Symptom burden in late stage Parkinsonism - Carer burden - Palliative care status - Nutritional status/BMI - Nursing home placement/institutionalisation - Place of death - Mortality Health care utilization Process evaluation: * Sampling quality: Proportion of eligible patients participating in the study, i.e. reach. * Intervention quality: -To what extent is the CLaSP-intervention implemented, ie. level of implementation? -What are the barriers and facilitators to implementation? * Reach: During patient recruitment, the researcher documents: -Number of potential participants, identified in databases and other sources, receiving a invitation letter for participation. -Number of potential participants agreeing to participate, before screening on eligibility -Number of participant fulfilling inclusion criteria and included in the study -Number of participant not fulfilling inclusion criteria and reasons for exclusion

—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)